Market Research Port offers you a comprehensive market research report on the Polyethylene Glycol industry. Based on this report data, you can gather valuable information on the Polyethylene Glycol industry covering key industry aspects like size, shares, market trends, key players, forecast, risk factors, game-changers, revenue prediction, future revenue streams, market instabilities, and profitability.
The market research report is ideal for investors who are looking to gain insightful knowledge of the Polyethylene Glycol industry, and what significant developments are to be expected. Each segment of the Polyethylene Glycol industry has been carefully segmented for you to find the exact information you are looking for, and get data on business opportunities, CAGR, regional analysis, segmentation, SWOT analysis, PEST analysis, competitor analysis, market assessment, growth plans, risk analysis. Actamax Surgical Materials, Llc, Adhesys Medical Gmbh, Adhezion Biomedical and more - all the leading companies operating in the Polyethylene Glycol market have been profiled and analyzed in the report.
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Polyethylene Glycol market in this environment.
In terms of revenue, this research report indicated that the global Polyethylene Glycol market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Polyethylene Glycol industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Actamax Surgical Materials, LLC aims at producing XX Polyethylene Glycol in 2020, with XX % production to take place in global market, Adhesys Medical GmbH accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Polyethylene Glycol Market includes:
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Polyethylene Glycol Market
Actamax Surgical Materials, LLC
Adhesys Medical GmbH
Adhezion Biomedical, LLC
Arch Therapeutics, Inc.
Baxter International, Inc.
B. Braun Melsungen AG
Biomedica Management Corporation
Biom'Up SAS
C.R. Bard (Bard Medical, Davol)
Cardinal Health
Gelita Medical AG
GluStitch, Inc.
Grifols International, S.A.
Hemostasis, LLC
Major Type of Polyethylene Glycol Covered in this Report:
Pharmaceutical Grade
Food Grade
Chemical Grade
Application Segments Covered in this Report:
Food Industry
Pharmaceutical
Chemical Industry
Cosmetics
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Pharmaceutical Grade -Product Introduction and Major Manufacturers
1.1.2 Food Grade -Product Introduction and Major Manufacturers
1.1.3 Chemical Grade -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Polyethylene Glycol Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Polyethylene Glycol Market
3.1.1 Top Companies leading Polyethylene Glycol Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Polyethylene Glycol Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Polyethylene Glycol Market
3.2.1 Top Companies leading Polyethylene Glycol Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Polyethylene Glycol Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Polyethylene Glycol Market
3.3.1 Top Companies leading Polyethylene Glycol Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Polyethylene Glycol Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Polyethylene Glycol Market
3.4.1 Top Companies leading Polyethylene Glycol Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Polyethylene Glycol Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Polyethylene Glycol Market
3.5.1 Top Companies leading Polyethylene Glycol Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Polyethylene Glycol Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Polyethylene Glycol Market
3.6.1 Top Companies leading Polyethylene Glycol Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Polyethylene Glycol Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Polyethylene Glycol Market
3.7.1 Top Companies leading Polyethylene Glycol Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Polyethylene Glycol Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Polyethylene Glycol Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Polyethylene Glycol Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Polyethylene Glycol Sales and Growth Rate (2021-2026)
5.2 Global Polyethylene Glycol Sales Value and Growth Rate (2021-2026)
6 Polyethylene Glycol Competitive Analysis
6.1 Actamax Surgical Materials, LLC
6.1.1 Actamax Surgical Materials, LLC Company Profiles
6.1.2 Actamax Surgical Materials, LLC Product Introduction
6.1.3 Actamax Surgical Materials, LLC Polyethylene Glycol Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 Adhesys Medical GmbH
6.2.1 Adhesys Medical GmbH Company Profiles
6.2.2 Adhesys Medical GmbH Product Introduction
6.2.3 Adhesys Medical GmbH Polyethylene Glycol Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Adhezion Biomedical, LLC
6.3.1 Adhezion Biomedical, LLC Company Profiles
6.3.2 Adhezion Biomedical, LLC Product Introduction
6.3.3 Adhezion Biomedical, LLC Polyethylene Glycol Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Arch Therapeutics, Inc.
6.4.1 Arch Therapeutics, Inc. Company Profiles
6.4.2 Arch Therapeutics, Inc. Product Introduction
6.4.3 Arch Therapeutics, Inc. Polyethylene Glycol Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Baxter International, Inc.
6.5.1 Baxter International, Inc. Company Profiles
6.5.2 Baxter International, Inc. Product Introduction
6.5.3 Baxter International, Inc. Polyethylene Glycol Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 B. Braun Melsungen AG
6.6.1 B. Braun Melsungen AG Company Profiles
6.6.2 B. Braun Melsungen AG Product Introduction
6.6.3 B. Braun Melsungen AG Polyethylene Glycol Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Biomedica Management Corporation
6.7.1 Biomedica Management Corporation Company Profiles
6.7.2 Biomedica Management Corporation Product Introduction
6.7.3 Biomedica Management Corporation Polyethylene Glycol Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Biom'Up SAS
6.8.1 Biom'Up SAS Company Profiles
6.8.2 Biom'Up SAS Product Introduction
6.8.3 Biom'Up SAS Polyethylene Glycol Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 C.R. Bard (Bard Medical, Davol)
6.9.1 C.R. Bard (Bard Medical, Davol) Company Profiles
6.9.2 C.R. Bard (Bard Medical, Davol) Product Introduction
6.9.3 C.R. Bard (Bard Medical, Davol) Polyethylene Glycol Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
6.10 Cardinal Health
6.10.1 Cardinal Health Company Profiles
6.10.2 Cardinal Health Product Introduction
6.10.3 Cardinal Health Polyethylene Glycol Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
6.11 Gelita Medical AG
6.12 GluStitch, Inc.
6.13 Grifols International, S.A.
6.14 Hemostasis, LLC
7 Conclusion
